Back to Discover

Zymeworks Inc.

ZYME · Biotech · Nasdaq · As of 10 Sep 2026
62AIR SCORE
  • FundamentalsNot enough data yet
  • ValueNot enough data yet
  • News flowBalanced
  • MomentumStrong
  • SafetyStrong

Overall confidence 41/100 — few inputs available yet

Fundamental score not available. AIR's fundamental engine is built for businesses with established revenue and cash flow; biotech financial profiles — often R&D-heavy or pre-revenue — don't yet fit the measures it requires. AIR still assesses this company on discovery, market confirmation and risk, at reduced overall confidence.

Discovery Gap: Very high (61/100) · Gap confidence 64/100Documented progress is running well ahead of market attention.

This month at a glance

AIR Score™ change: -1Slipped -1 on softer inputs.
Cycle window9 Sep 202610 Sep 2026
Momentum-1Weighed on the latest score.

Evidence timeline

  1. [8-K 8.01] Zymeworks Inc. — Other EventsSEC · SEC EDGAR
    Aug 25, 2026 · 8-K
  2. [8-K 2.02] Zymeworks Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Aug 6, 2026 · 8-K
  3. [8-K 1.01] Zymeworks Inc. — Entry into a Material Definitive AgreementSEC · SEC EDGAR
    Jun 28, 2026 · 8-K
  4. [8-K 8.01] Zymeworks Inc. — Other EventsSEC · SEC EDGAR
    May 14, 2026 · 8-K
  5. [8-K 2.02] Zymeworks Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    May 7, 2026 · 8-K
  6. [8-K 5.02] Zymeworks Inc. — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Mar 31, 2026 · 8-K
  7. [8-K 2.03] Zymeworks Inc. — Creation of a Material Direct Financial ObligationSEC · SEC EDGAR
    Mar 2, 2026 · 8-K
  8. [8-K 1.01] Zymeworks Inc. — Entry into a Material Definitive AgreementSEC · SEC EDGAR
    Mar 2, 2026 · 8-K
  9. [8-K 2.02] Zymeworks Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Mar 2, 2026 · 8-K
  10. [8-K 2.02] Zymeworks Inc. — Results of Operations and Financial ConditionSEC · SEC EDGAR
    Jan 6, 2026 · 8-K
  11. [8-K 8.01] Zymeworks Inc. — Other EventsSEC · SEC EDGAR
    Jan 6, 2026 · 8-K
  12. [8-K 5.02] Zymeworks Inc. — Departure/Election of Directors or Principal OfficersSEC · SEC EDGAR
    Jan 6, 2026 · 8-K

Ask AIR

What would change our view

A weaker balance sheet in the next filing cycle, a material regulatory setback, or attention arriving — which closes the gap by design would move the score, and the page would show which one did.

Research, not tips. No buy/sell recommendations, no price forecasts. Every score is derived from public filings and market data — figures round to whole numbers and refresh each trading day.

ZYME — Zymeworks Inc. · AIR Discovery Research